These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22343809)

  • 1. The right medicines--just not enough of them.
    Honig PK
    Clin Pharmacol Ther; 2012 Mar; 91(3):369-72. PubMed ID: 22343809
    [No Abstract]   [Full Text] [Related]  

  • 2. Wrong questions, wrong answers? Are we getting the drugs we need?
    Lipworth WL; Kerridge IH; Day RO
    Clin Pharmacol Ther; 2012 Mar; 91(3):367-9. PubMed ID: 22343808
    [No Abstract]   [Full Text] [Related]  

  • 3. Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.
    Wang N; Lipworth WL; Ritchie JE; Williams KM; Day RO
    Intern Med J; 2011 Apr; 41(4):314-20. PubMed ID: 20403068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous flow synthesis. A pharma perspective.
    Malet-Sanz L; Susanne F
    J Med Chem; 2012 May; 55(9):4062-98. PubMed ID: 22283413
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22666880
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 7. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 8. Learning lessons from drugs that have recently entered the market.
    Teague SJ
    Drug Discov Today; 2011 May; 16(9-10):398-411. PubMed ID: 21414418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where do innovative drugs come from?
    Higgs G
    Drug Discov Today; 2011 Nov; 16(21-22):907-9. PubMed ID: 21889605
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can biochemistry drive drug discovery beyond simple potency measurements?
    Chène P
    Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the 'organizational factor' on compound quality in drug discovery.
    Leeson PD; St-Gallay SA
    Nat Rev Drug Discov; 2011 Sep; 10(10):749-65. PubMed ID: 21959288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medicines shortage: Moving towards "regressive" medicine?].
    Dupin N; Bédane C
    Ann Dermatol Venereol; 2015; 142(6-7):391-2. PubMed ID: 25701097
    [No Abstract]   [Full Text] [Related]  

  • 14. An industry perspective on tiered approach to the investigation of metabolites in drug development.
    Huskey SE; Li W; Mangold JB; Flarakos J
    Bioanalysis; 2014 Mar; 6(5):617-28. PubMed ID: 24620804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deconstructing the drug development process: the new face of innovation.
    Kaitin KI
    Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-on drugs: how far should chemists look?
    Giordanetto F; Boström J; Tyrchan C
    Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process.
    Alonso A; Milanzi E; Molenberghs G; Buyck C; Bijnens L
    Pharm Stat; 2015; 14(2):129-38. PubMed ID: 25420717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crowdsourcing in pharmaceutical R&D: a revolutionary concept or nothing new?
    Song CH
    Pharm Pat Anal; 2016 Sep; 5(6):355-360. PubMed ID: 27804785
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.
    Jones HM; Chen Y; Gibson C; Heimbach T; Parrott N; Peters SA; Snoeys J; Upreti VV; Zheng M; Hall SD
    Clin Pharmacol Ther; 2015 Mar; 97(3):247-62. PubMed ID: 25670209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting physical to fix pharma.
    Connelly PR; Vuong TM; Murcko MA
    Nat Chem; 2011 Aug; 3(9):692-5. PubMed ID: 21860457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.